Groove Botanicals Inc. (GRVE) EBIT (2010 - 2026)

Groove Botanicals has disclosed EBIT across 13 years of filings, most recently posting -$28318.0 for Q2 2026.

• In Q2 2026, EBIT rose 25.81% year-over-year to -$28318.0; the TTM figure through Jun 2026 stood at -$130065.0 (up 1.81% YoY), while the FY2026 annual figure was -$139917.0, down 6.94% from the prior year.
• EBIT came in at -$28318.0 for Q2 2026 at Groove Botanicals, up from -$35497.0 in the prior quarter.
• In the past five years, EBIT ranged from a high of -$27795.0 in Q3 2023 to a low of -$123977.0 in Q2 2023.
• Average EBIT over 5 years is -$43796.5, with a median of -$36018.0 recorded in 2024.
• Year-over-year, EBIT tumbled 46.74% in 2023 and jumped 70.53% in 2024.
• Over 5 years, EBIT stood at -$37615.0 in 2022, then plunged by 46.74% to -$55196.0 in 2023, then soared by 40.16% to -$33031.0 in 2024, then dropped by 2.53% to -$33867.0 in 2025, then rose by 16.38% to -$28318.0 in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$28318.0 in Q2 2026, -$35497.0 in Q1 2026, and -$33867.0 in Q4 2025.